CANNABIS:  INFARMED – Immediate suspension of marketing and withdrawal from the national market

CANNABIS: INFARMED – Immediate suspension of marketing and withdrawal from the national market

Immediate suspension of marketing and withdrawal from the national market of batches of BB Cream CBD Light, BB Cream CBD Medium, CBD Mascara and CBD Lipstick No. 3 (Dermacol)

 

10 Feb 2025

The use of cannabis derivatives in cosmetic products is legally regulated by Regulation (EC) No. 1223/2009 of November 30 (and respective updates), by Regulation (EU) No. 655/2013 of July 10 and by Decree-Law No. 15/93 of January 22 in its current wording.

In this sense, cosmetic products cannot contain the following substances/preparations related to the cannabis plant, regardless of their tetrahydrocannabinol (THC) content: Cannabis and Cannabis resin; Cannabis extracts and tinctures; Leaves and flowering/flowering or fruiting tops of the Cannabis plant. The inclusion of CBD or other cannabinoids, which exist naturally in the cannabis plant, is not permitted, as they are obtained through the preparation of extracts or tinctures of Cannabis or its resin. (…) The use of substances/preparations obtained from plant seeds with a THC content of ≤0.2%, such as cannabis seed oil, from varieties registered in the Common Catalogue of Varieties of Agricultural Species, is exempt from this prohibition.

 

Following an ongoing inspection action, INFARMED, I.P. found that the products BB Cream CBD Light, BB Cream CBD Medium, CBD Mascara and CBD Lipstick No. 3 of the Dermacol brand, whose Responsible Person is the entity Dermacol a.s. (based in Czech Republic) are sold on the domestic market.

These products contain cannabidiol in their composition, a substance that, because it is obtained through extracts from the leaves of Cannabis plants, is prohibited in the composition of cosmetic products.

 

Immediate suspension of marketing and withdrawal from the national market of all batches of several Origin products from the Naturasor brand

10 Feb 2025

The use of cannabis derivatives in cosmetic products is legally regulated by Regulation (EC) No. 1223/2009 of 30 November (and respective updates), by Regulation (EU) No. 655/2013 of 10 July and by Decree-Law No.

 

In this sense, cosmetic products cannot contain the following substances/preparations related to the cannabis plant, regardless of their tetrahydrocannabinol (THC) content: Cannabis and Cannabis resin; Cannabis extracts and tinctures; Leaves and flowering/flowering or fruiting tops of the cannabis plant. The inclusion of CBD or other cannabinoids, which exist naturally in the cannabis plant, is not permitted, as they are obtained through the preparation of extracts or tinctures of Cannabis or its resin. (…) The use of substances/preparations obtained from plant seeds with a THC content of ≤0.2%, such as cannabis seed oil, from varieties registered in the Common Catalogue of Varieties of Agricultural Species, is exempt from this prohibition.

 

Following an ongoing inspection action, INFARMED, I.P. found that the products Origin – CBD Hot Cream, Origin – CBD Cold Cream, Origin – Natural Oil Blend CBD 10%, Origin – Natural Oil Blend CBD 20%, Origin – Natural Oil Blend CBD 30% and Origin – Natural Oil Blend 15% CBD + Melatonin, whose Responsible Person is the entity Laboratorios Naturasor S.L (based in Spain) are marketed in the national market.

These products contain cannabidiol in their composition, a substance that, as it is obtained through extracts from the leaves of marijuana plants, is prohibited in the composition of cosmetic products, which is why they are not compliant.

 

Immediate suspension of marketing and withdrawal from the national market of all batches of the product SVR CBD Ampoule Resist

10 Feb 2025

The use of cannabis derivatives in cosmetic products is legally regulated by Regulation (EC) No. 1223/2009 of 30 November (and respective updates), by Regulation (EU) No. 655/2013 of 10 July and by Decree-Law No.

 

In this sense, cosmetic products cannot contain the following substances/preparations related to the cannabis plant, regardless of their tetrahydrocannabinol (THC) content: Cannabis and Cannabis resin; Cannabis extracts and tinctures; Leaves and flowering/flowering or fruiting tops of the Cannabis plant. The inclusion of CBD or other cannabinoids, which exist naturally in the cannabis plant, is not permitted, as they are obtained through the preparation of extracts or tinctures of Cannabis or its resin. (…) The use of substances/preparations obtained from plant seeds with a THC content of ≤0.2%, such as cannabis seed oil, from varieties registered in the Common Catalogue of Varieties of Agricultural Species, is exempt from this prohibition.

 

Following a market inspection action, INFARMED, I.P. found that the product SVR CBD Ampoule Resist, whose distributor in Portugal is the company Cosveritas Portugal, Unipessoal Lda. is sold on the national market.

 

This product contains cannabidiol in its composition, a substance that, as it is obtained through extracts from the leaves of cannabis plants, is prohibited in the composition of cosmetic products, therefore it is not compliant.

 

Source: INFARMED

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

www.manostaxx.com

 

Manostaxx
Manostaxx – Industrial Management Consulting

Comments

No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *